Cantitate/Preț
Produs

Fragment-Based Drug Discovery and X-Ray Crystallography: Topics in Current Chemistry, cartea 317

Editat de Thomas G. Davies, Marko Hyvönen
en Limba Engleză Paperback – 22 feb 2014
Introduction to Fragment-Based Drug Discovery, by Daniel A. Erlanson
Fragment Screening Using X-Ray Crystallography, by Thomas G. Davies and Ian J. Tickle
Hsp90 Inhibitors and Drugs from Fragment and Virtual Screening, by Stephen Roughley, Lisa Wright, Paul Brough, Andrew Massey and Roderick E. Hubbard
Combining NMR and X-ray Crystallography in Fragment-Based Drug Discovery: Discovery of Highly Potent and Selective BACE-1 Inhibitors, by Daniel F. Wyss, Yu-Sen Wang, Hugh L. Eaton, Corey Strickland, Johannes H. Voigt, Zhaoning Zhu and Andrew W. Stamford
Combining Biophysical Screening and X-Ray Crystallography for Fragment-Based Drug Discovery, by Michael Hennig, Armin Ruf and Walter Huber
Targeting Protein–Protein Interactions and Fragment-Based Drug Discovery, by Eugene Valkov, Tim Sharpe, May Marsh, Sandra Greive and Marko Hyvönen
Fragment Screening and HIV Therapeutics, by Joseph D. Bauman, Disha Patel and Eddy Arnold
Fragment-Based Approaches and Computer-Aided Drug Discovery, by Didier Rognan
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 177630 lei  6-8 săpt.
  Springer Berlin, Heidelberg – 22 feb 2014 177630 lei  6-8 săpt.
Hardback (1) 178019 lei  6-8 săpt.
  Springer Berlin, Heidelberg – 23 ian 2012 178019 lei  6-8 săpt.

Din seria Topics in Current Chemistry

Preț: 177630 lei

Preț vechi: 216621 lei
-18% Nou

Puncte Express: 2664

Preț estimativ în valută:
33995 35312$ 28238£

Carte tipărită la comandă

Livrare economică 03-17 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783642446351
ISBN-10: 3642446353
Pagini: 240
Ilustrații: XII, 228 p.
Dimensiuni: 155 x 235 x 13 mm
Greutate: 0.34 kg
Ediția:2012
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Topics in Current Chemistry

Locul publicării:Berlin, Heidelberg, Germany

Public țintă

Research

Cuprins

D. A. Erlanson
Introduction to Fragment-Based Drug Discovery.-
T. G. Davies
Ian J. Tickle
Fragment Screening Using X-Ray Crystallography.-
S. Roughley
L. Wright
P. Brough
A. Massey
R. E. Hubbard
Hsp90 Inhibitors and Drugs from Fragment and Virtual Screening.-
D. F. Wyss
Y.-S. Wang
H. L. Eaton
C. Strickland
J.s H. Voigt
Z. Zhu
A. W. Stamford
Combining NMR and X-ray Crystallography in Fragment-Based Drug Discovery: Discovery of Highly Potent and Selective BACE-1 Inhibitors.-
M. Hennig
A. Ruf
Walter HuberCombining Biophysical Screening and X-Ray Crystallography for Fragment-Based Drug Discovery.-
E. Valkov
T. Sharpe
M. Marsh
Sa. Greive
M. Hyvönen
Targeting Protein–Protein Interactions and Fragment-Based Drug Discovery.-
J.h D. Bauman
D. Patel
E. Arnold
Fragment Screening and HIV Therapeutics.-
D. Rognan
Fragment-Based Approaches and Computer-Aided Drug Discovery.

Textul de pe ultima copertă

D. A. ErlansonIntroduction to Fragment-Based Drug DiscoveryT. G. DaviesIan J. TickleFragment Screening Using X-Ray CrystallographyS. RoughleyL. WrightP. BroughA. Massey R. E. HubbardHsp90 Inhibitors and Drugs from Fragment and Virtual ScreeningD. F. WyssY.-S. WangH. L. EatonC. StricklandJ.s H. VoigtZ. Zhu A. W. StamfordCombining NMR and X-ray Crystallography in Fragment-Based Drug Discovery: Discovery of Highly Potent and Selective BACE-1 InhibitorsM. HennigA. Ruf Walter HuberCombining Biophysical Screening and X-Ray Crystallography for Fragment-Based Drug DiscoveryE. ValkovT. SharpeM. MarshSa. Greive M. HyvönenTargeting Protein–Protein Interactions and Fragment-Based Drug DiscoveryJ.h D. BaumanD. Patel E. ArnoldFragment Screening and HIV TherapeuticsD. RognanFragment-Based Approaches and Computer-Aided Drug Discovery

Caracteristici

This series presents critical reviews of the present position and future trends in modern chemical research Short and concise reports on chemistry, each written by the world renowned experts Still valid and useful after 5 or 10 years More information as well as the electronic version of the whole content available at: springerlink.com Includes supplementary material: sn.pub/extras